Loading...

Synlab AG

SYAB.DEXETRA
Healthcare
Medical - Diagnostics & Research
11.06
-0.02(-0.18%)
German Market is Open • 13:01

Synlab AG Fundamental Analysis

Synlab AG (SYAB.DE) shows weak financial fundamentals with a PE ratio of 26.34, profit margin of 3.50%, and ROE of 10.58%. The company generates $2.6B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position10.93%
PEG Ratio0.26

Areas of Concern

Operating Margin4.45%
We analyze SYAB.DE's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 42.4/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
42.4/100

We analyze SYAB.DE's fundamental strength across five key dimensions:

Efficiency Score

Weak

SYAB.DE struggles to generate sufficient returns from assets.

ROA > 10%
1.98%

Valuation Score

Moderate

SYAB.DE shows balanced valuation metrics.

PE < 25
26.34
PEG Ratio < 2
0.26

Growth Score

Moderate

SYAB.DE shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

SYAB.DE maintains a strong and stable balance sheet.

Debt/Equity < 1
0.67
Current Ratio > 1
1.16

Profitability Score

Weak

SYAB.DE struggles to sustain strong margins.

ROE > 15%
10.58%
Net Margin ≥ 15%
3.50%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is SYAB.DE Expensive or Cheap?

P/E Ratio

SYAB.DE trades at 26.34 times earnings. This indicates a fair valuation.

26.34

PEG Ratio

When adjusting for growth, SYAB.DE's PEG of 0.26 indicates potential undervaluation.

0.26

Price to Book

The market values Synlab AG at 1.04 times its book value. This may indicate undervaluation.

1.04

EV/EBITDA

Enterprise value stands at 2.65 times EBITDA. This is generally considered low.

2.65

How Well Does SYAB.DE Make Money?

Net Profit Margin

For every $100 in sales, Synlab AG keeps $3.50 as profit after all expenses.

3.50%

Operating Margin

Core operations generate 4.45 in profit for every $100 in revenue, before interest and taxes.

4.45%

ROE

Management delivers $10.58 in profit for every $100 of shareholder equity.

10.58%

ROA

Synlab AG generates $1.98 in profit for every $100 in assets, demonstrating efficient asset deployment.

1.98%

Following the Money - Real Cash Generation

Operating Cash Flow

Synlab AG produces operating cash flow of $363.22M, showing steady but balanced cash generation.

$363.22M

Free Cash Flow

Synlab AG produces free cash flow of $236.96M, offering steady but limited capital for shareholder returns and expansion.

$236.96M

FCF Per Share

Each share generates $1.08 in free cash annually.

$1.08

FCF Yield

SYAB.DE converts 9.75% of its market value into free cash.

9.75%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

26.34

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.26

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.04

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.92

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.67

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.16

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.11

vs 25 benchmark

ROA

Return on assets percentage

0.02

vs 25 benchmark

ROCE

Return on capital employed

0.03

vs 25 benchmark

How SYAB.DE Stacks Against Its Sector Peers

MetricSYAB.DE ValueSector AveragePerformance
P/E Ratio26.3429.17 Neutral
ROE10.58%701.00% Weak
Net Margin3.50%-43676.00% (disorted) Weak
Debt/Equity0.670.34 Weak (High Leverage)
Current Ratio1.164.45 Neutral
ROA1.98%-18965.00% (disorted) Weak

SYAB.DE outperforms its industry in 0 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Synlab AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ